Your session is about to expire
← Back to Search
Phonological Pattern Learning for Language Disorder in Toddlers
N/A
Recruiting
Led By LouAnn Gerken, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up generalization phase which will last 3-5 minutes
Awards & highlights
Study Summary
This trial is testing whether children with language disorders have difficulty learning patterns, and whether this impacts their speech.
Who is the study for?
This trial is for toddlers with no medical or developmental concerns, normal speech, social, and motor development, dominant exposure to English from infancy, normal hearing, and expressive vocabulary above the 10th percentile. Toddlers with hearing or intellectual impairments, autism, reported developmental disorders or significant motor impairment cannot participate.Check my eligibility
What is being tested?
The study tests if there's a link between morphological and phonological deficits in language learning by observing toddlers' sensitivity to phonological rules. It aims to improve assessments and interventions for children with developmental language disorder (DLD) or specific language impairment (SLI).See study design
What are the potential side effects?
Since this trial involves observational studies of toddler behavior rather than medical interventions, traditional side effects are not applicable. However, participation may involve time commitment and interaction with researchers.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ generalization phase which will last 3-5 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~generalization phase which will last 3-5 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Toddlers' ability to learn different types of sound patterns measured by listening times
Trial Design
2Treatment groups
Experimental Treatment
Group I: Sensitivity to phonological rules & referents OR: ToddlersExperimental Treatment1 Intervention
OR condition
Group II: Sensitivity to phonological rules & referents FR: ToddlersExperimental Treatment1 Intervention
Family Resemblance condition
Find a Location
Who is running the clinical trial?
University of ArizonaLead Sponsor
517 Previous Clinical Trials
148,353 Total Patients Enrolled
3 Trials studying Language Developmental Disorders
472 Patients Enrolled for Language Developmental Disorders
The University of Texas at DallasOTHER
60 Previous Clinical Trials
106,429 Total Patients Enrolled
2 Trials studying Language Developmental Disorders
1,660 Patients Enrolled for Language Developmental Disorders
LouAnn Gerken, PhDPrincipal Investigator - University of Arizona
University of Arizona
1 Previous Clinical Trials
1,260 Total Patients Enrolled
1 Trials studying Language Developmental Disorders
1,260 Patients Enrolled for Language Developmental Disorders
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have significant problems with movement.I do not have a history of developmental, speech, language, or hearing disorders.You will be excluded if you have trouble hearing.My toddler has no medical or developmental issues, according to our doctor.My child has been mainly exposed to English since birth, according to my observations.Toddlers should have normal language, speech, social, and motor development based on their parents' reports.Toddlers must have normal hearing based on their parents' report.Toddlers must have a vocabulary that is as good or better than 90% of other toddlers, based on what their parents say.
Research Study Groups:
This trial has the following groups:- Group 1: Sensitivity to phonological rules & referents OR: Toddlers
- Group 2: Sensitivity to phonological rules & referents FR: Toddlers
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger